The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulam, P. G.
Right arrow Articles by Shearer, W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulam, P. G.
Right arrow Articles by Shearer, W. T.

The Journal of Immunology, Vol 146, Issue 5 1642-1648, Copyright © 1991 by American Association of Immunologists

ARTICLES

Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line

PG Schulam, A Kuruvilla, G Putcha, L Mangus, J Franklin-Johnson and WT Shearer
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.

Platelet-activating factor is a potent mediator of the inflammatory response. Studies of the actions of platelet-activating factor have centered mainly around neutrophils, monocytes, and platelets. In this report we begin to uncover the influence of platelet-activating factor on B lymphocytes. Employing the EBV-transformed human B cell line SKW6.4, we demonstrate that platelet-activating factor significantly alters membrane phospholipid metabolism indicated by the incorporation of 32P into phosphatidylcholine, phosphatidylinositol, and phosphatidic acid but not significantly into phosphatidylethanolamine at concentrations ranging from 10(-9) to 10(-6) M. The inactive precursor, lyso-platelet-activating factor, at a concentration as high as 10(-7) M had no effect on any of the membrane phospholipids. We also show that platelet-activating factor from 10(-12) to 10(-6) M induced rapid and significant elevation in intracellular calcium levels, whereas lyso- platelet-activating factor was again ineffective. We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production. Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun. Finally we explored the possible role of 5-hydroxyeicosatetraenoic acid as a regulator of arachidonic acid liberation demonstrating that endogenous 5- lipoxygenase activity modulates platelet-activating factor induced arachidonic acid release perhaps acting at the level of phospholipase A2. In summary, platelet-activating factor is shown here to have a direct and profound effect on a pure B cell line.


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
G. Montrucchio, G. Alloatti, and G. Camussi
Role of Platelet-Activating Factor in Cardiovascular Pathophysiology
Physiol Rev, October 1, 2000; 80(4): 1669 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Zhuang, Y. Bastien, and B. D. Mazer
Activation Via Multiple Signaling Pathways Induces Down-Regulation of Platelet-Activating Factor Receptors on Human B Lymphocytes
J. Immunol., September 1, 2000; 165(5): 2423 - 2431.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Bastien, B. J. Toledano, N. Mehio, L. Cameron, B. Lamoukhaid, P. Renzi, Q. Hamid, and B. D. Mazer
Detection of Functional Platelet-Activating Factor Receptors on Human Tonsillar B Lymphocytes
J. Immunol., May 1, 1999; 162(9): 5498 - 5505.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Kotelevets, V. Noe, E. Bruyneel, E. Myssiakine, E. Chastre, M. Mareel, and C. Gespach
Inhibition by Platelet-activating Factor of Src- and Hepatocyte Growth Factor-dependent Invasiveness of Intestinal and Kidney Epithelial Cells. PHOSPHATIDYLINOSITOL 3'-KINASE IS A CRITICAL MEDIATOR OF TUMOR INVASION
J. Biol. Chem., June 5, 1998; 273(23): 14138 - 14145.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. D. Levan, J. W. Bloom, D. G. Adams, J. L. Hensel, and M. Halonen
Platelet-Activating Factor Induction of Activator Protein-1 Signaling in Bronchial Epithelial Cells
Mol. Pharmacol., January 1, 1998; 53(1): 135 - 140.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. M. Ferby, I. Waga, M. Hoshino, K. Kume, and T. Shimizu
Wortmannin Inhibits Mitogen-activated Protein Kinase Activation by Platelet-activating Factor through a Mechanism Independent of p85/p110-type Phosphatidylinositol 3-Kinase
J. Biol. Chem., May 17, 1996; 271(20): 11684 - 11688.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. V. Kravchenko, Z. Pan, J. Han, J.-M. Herbert, R. J. Ulevitch, and R. D. Ye
Platelet-activating Factor Induces NF-[IMAGE]B Activation through a G Protein-coupled Pathway
J. Biol. Chem., June 23, 1995; 270(25): 14928 - 14934.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.